148 related articles for article (PubMed ID: 32787106)
1. Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses.
Riva V; Garbelli A; Brai A; Casiraghi F; Fazi R; Trivisani CI; Boccuto A; Saladini F; Vicenti I; Martelli F; Zazzi M; Giannecchini S; Dreassi E; Botta M; Maga G
J Med Chem; 2020 Sep; 63(17):9876-9887. PubMed ID: 32787106
[TBL] [Abstract][Full Text] [Related]
2. DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection.
Brai A; Martelli F; Riva V; Garbelli A; Fazi R; Zamperini C; Pollutri A; Falsitta L; Ronzini S; Maccari L; Maga G; Giannecchini S; Botta M
J Med Chem; 2019 Mar; 62(5):2333-2347. PubMed ID: 30721061
[TBL] [Abstract][Full Text] [Related]
3. RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X.
Yang SNY; Atkinson SC; Audsley MD; Heaton SM; Jans DA; Borg NA
Cells; 2020 Jan; 9(1):. PubMed ID: 31936642
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X.
Brai A; Ronzini S; Riva V; Botta L; Zamperini C; Borgini M; Trivisani CI; Garbelli A; Pennisi C; Boccuto A; Saladini F; Zazzi M; Maga G; Botta M
Molecules; 2019 Nov; 24(21):. PubMed ID: 31690062
[TBL] [Abstract][Full Text] [Related]
5. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.
Brai A; Fazi R; Tintori C; Zamperini C; Bugli F; Sanguinetti M; Stigliano E; Esté J; Badia R; Franco S; Martinez MA; Martinez JP; Meyerhans A; Saladini F; Zazzi M; Garbelli A; Maga G; Botta M
Proc Natl Acad Sci U S A; 2016 May; 113(19):5388-93. PubMed ID: 27118832
[TBL] [Abstract][Full Text] [Related]
6. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
7. DEAD-Box Helicase DDX3X as a Host Target against Emerging Viruses: New Insights for Medicinal Chemical Approaches.
Brai A; Trivisani CI; Poggialini F; Pasqualini C; Vagaggini C; Dreassi E
J Med Chem; 2022 Aug; 65(15):10195-10216. PubMed ID: 35899912
[TBL] [Abstract][Full Text] [Related]
8. Peptide-β-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes.
Dražić T; Kopf S; Corridan J; Leuthold MM; Bertoša B; Klein CD
J Med Chem; 2020 Jan; 63(1):140-156. PubMed ID: 31804823
[TBL] [Abstract][Full Text] [Related]
9. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
10. Discovery of host-targeted covalent inhibitors of dengue virus.
de Wispelaere M; Carocci M; Liang Y; Liu Q; Sun E; Vetter ML; Wang J; Gray NS; Yang PL
Antiviral Res; 2017 Mar; 139():171-179. PubMed ID: 28034743
[TBL] [Abstract][Full Text] [Related]
11. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
Parkinson T; Pryde DC
Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
[TBL] [Abstract][Full Text] [Related]
12. Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions.
Cannalire R; Tarantino D; Piorkowski G; Carletti T; Massari S; Felicetti T; Barreca ML; Sabatini S; Tabarrini O; Marcello A; Milani M; Cecchetti V; Mastrangelo E; Manfroni G; Querat G
Antiviral Res; 2019 Jul; 167():6-12. PubMed ID: 30849420
[TBL] [Abstract][Full Text] [Related]
13. Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.
Jiménez de Oya N; Esler WP; Huard K; El-Kattan AF; Karamanlidis G; Blázquez AB; Ramos-Ibeas P; Escribano-Romero E; Louloudes-Lázaro A; Casas J; Sobrino F; Hoehn K; James DE; Gutiérrez-Adán A; Saiz JC; Martín-Acebes MA
Emerg Microbes Infect; 2019; 8(1):624-636. PubMed ID: 30999821
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication.
Blázquez AB; Vázquez-Calvo Á; Martín-Acebes MA; Saiz JC
Viruses; 2018 Feb; 10(2):. PubMed ID: 29473907
[TBL] [Abstract][Full Text] [Related]
15. Dengue Virus Capsid Interacts with DDX3X-A Potential Mechanism for Suppression of Antiviral Functions in Dengue Infection.
Kumar R; Singh N; Abdin MZ; Patel AH; Medigeshi GR
Front Cell Infect Microbiol; 2017; 7():542. PubMed ID: 29387631
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 4'-Substituted-2'-Deoxy-2'-α-Fluoro Nucleoside Analogs as Potential Antiviral Agents.
Kasthuri M; Li C; Verma K; Russell OO; Dickson L; McCormick L; Bassit L; Amblard F; Schinazi RF
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168734
[TBL] [Abstract][Full Text] [Related]
17. Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors.
Fazi R; Tintori C; Brai A; Botta L; Selvaraj M; Garbelli A; Maga G; Botta M
J Chem Inf Model; 2015 Nov; 55(11):2443-54. PubMed ID: 26544088
[TBL] [Abstract][Full Text] [Related]
18. DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins.
Brai A; Riva V; Saladini F; Zamperini C; Trivisani CI; Garbelli A; Pennisi C; Giannini A; Boccuto A; Bugli F; Martini M; Sanguinetti M; Zazzi M; Dreassi E; Botta M; Maga G
Eur J Med Chem; 2020 Aug; 200():112319. PubMed ID: 32446036
[TBL] [Abstract][Full Text] [Related]
19. A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity.
Puschnik AS; Marceau CD; Ooi YS; Majzoub K; Rinis N; Contessa JN; Carette JE
Cell Rep; 2017 Dec; 21(11):3032-3039. PubMed ID: 29241533
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses.
Hackett BA; Dittmar M; Segrist E; Pittenger N; To J; Griesman T; Gordesky-Gold B; Schultz DC; Cherry S
mBio; 2019 Jul; 10(4):. PubMed ID: 31289184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
